Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
J Neurol Neurosurg Psychiatry
    September 2021
  1. CHONG JR, Ashton NJ, Karikari TK, Tanaka T, et al
    Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
    J Neurol Neurosurg Psychiatry. 2021 Sep 11. pii: jnnp-2021-327370.
    >> Share

    June 2021
  2. CHEUNG CY, Mok V, Foster PJ, Trucco E, et al
    Retinal imaging in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2021 Jun 9. pii: jnnp-2020-325347.
    >> Share

    April 2021
  3. SINGLETON E, Hansson O, Pijnenburg YAL, La Joie R, et al
    Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2021 Apr 13. pii: jnnp-2020-325497.
    >> Share

    February 2021
  4. OLIVEIRA FPM, Walker Z, Walker RWH, Attems J, et al
    (123)I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases.
    J Neurol Neurosurg Psychiatry. 2021 Feb 4. pii: jnnp-2020-324606.
    >> Share

    December 2020
  5. HALBGEBAUER S, Oeckl P, Steinacker P, Yilmazer-Hanke D, et al
    Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2020 Dec 30. pii: jnnp-2020-324306.
    >> Share

  6. FULLGRABE C
    When hearing loss masquerades as cognitive decline.
    J Neurol Neurosurg Psychiatry. 2020;91:1248.
    >> Share

    November 2020
  7. KEIR LHM, Breen DP
    REM sleep behaviour disorder in patients without synucleinopathy.
    J Neurol Neurosurg Psychiatry. 2020;91:1239-1240.
    >> Share

    October 2020
  8. CHU CS, Li CT, Brunoni AR, Yang FC, et al
    Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer's disease and mild cognitive impairment: a component network meta-analysis.
    J Neurol Neurosurg Psychiatry. 2020 Oct 28. pii: jnnp-2020-323870.
    >> Share

  9. LU L, Zheng X, Wang S, Tang C, et al
    Anti-Abeta agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2020 Oct 12. pii: jnnp-2020-323497.
    >> Share

  10. KOH W, Lim L, Low A, Wong B, et al
    Development and validation of a brief visual based cognitive screening tool for dementia: the Visual Cognitive Assessment Test short-form (VCAT-S).
    J Neurol Neurosurg Psychiatry. 2020;91:1122-1123.
    >> Share

    September 2020
  11. AMIN J, Boche D, Clough Z, Teeling J, et al
    Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer's disease: an observational clinical study.
    J Neurol Neurosurg Psychiatry. 2020 Sep 23. pii: jnnp-2020-323603.
    >> Share

  12. LOGROSCINO G
    Prevention of Alzheimer's disease and dementia: the evidence is out there, but new high-quality studies and implementation are needed.
    J Neurol Neurosurg Psychiatry. 2020 Sep 15. pii: jnnp-2020-323606.
    >> Share

  13. LOW A, Mak E, Malpetti M, Passamonti L, et al
    In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2020 Sep 11. pii: jnnp-2020-323894.
    >> Share

  14. AGIN A, Blanc F, Bousiges O, Villette C, et al
    Environmental exposure to phthalates and dementia with Lewy bodies: contribution of metabolomics.
    J Neurol Neurosurg Psychiatry. 2020;91:968-974.
    >> Share

  15. BENUSSI A, Karikari TK, Ashton N, Gazzina S, et al
    Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration.
    J Neurol Neurosurg Psychiatry. 2020;91:960-967.
    >> Share

    July 2020
  16. YU JT, Xu W, Tan CC, Andrieu S, et al
    Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials.
    J Neurol Neurosurg Psychiatry. 2020 Jul 20. pii: jnnp-2019-321913.
    >> Share

    May 2020
  17. CHEN S, Honda T, Ohara T, Hata J, et al
    Serum homocysteine and risk of dementia in Japan.
    J Neurol Neurosurg Psychiatry. 2020;91:540-546.
    >> Share

  18. SENOVA S, Fomenko A, Gondard E, Lozano AM, et al
    Anatomy and function of the fornix in the context of its potential as a therapeutic target.
    J Neurol Neurosurg Psychiatry. 2020;91:547-559.
    >> Share

    December 2019
  19. GATCHEL JR, Lopera F, Norton DJ, Baena A, et al
    Association of subjective cognitive decline with markers of brain pathology in preclinical autosomal dominant Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2019 Dec 24. pii: jnnp-2019-321205.
    >> Share

    August 2019
  20. SMITH C, Malek N, Grosset K, Cullen B, et al
    Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies.
    J Neurol Neurosurg Psychiatry. 2019 Aug 23. pii: jnnp-2019-321111.
    >> Share

  21. TEUBER-HANSELMANN S, Rekowski J, Vogelgsang J, von Arnim C, et al
    CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2019 Aug 1. pii: jnnp-2019-321073.
    >> Share

  22. BLENNOW K, Diaz-Lucena D, Zetterberg H, Villar-Pique A, et al
    CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
    J Neurol Neurosurg Psychiatry. 2019;90:846-853.
    >> Share

    July 2019
  23. JIA J, Hu J, Huo X, Miao R, et al
    Effects of vitamin D supplementation on cognitive function and blood Abeta-related biomarkers in older adults with Alzheimer's disease: a randomised, double-blind, placebo-controlled trial.
    J Neurol Neurosurg Psychiatry. 2019 Jul 11. pii: jnnp-2018-320199.
    >> Share

    April 2019
  24. FOIANI MS, Cicognola C, Ermann N, Woollacott IOC, et al
    Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest.
    J Neurol Neurosurg Psychiatry. 2019 Apr 13. pii: jnnp-2018-319266.
    >> Share

  25. HOU XH, Feng L, Zhang C, Cao XP, et al
    Models for predicting risk of dementia: a systematic review.
    J Neurol Neurosurg Psychiatry. 2019;90:373-379.
    >> Share

    February 2019
  26. ALCOLEA D, Irwin DJ, Illan-Gala I, Munoz L, et al
    Elevated YKL-40 and low sAPPbeta:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD.
    J Neurol Neurosurg Psychiatry. 2019;90:180-186.
    >> Share

    January 2019
  27. SHEN XN, Niu LD, Wang YJ, Cao XP, et al
    Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies.
    J Neurol Neurosurg Psychiatry. 2019 Jan 10. pii: jnnp-2018-319148.
    >> Share

    December 2018
  28. MOTTA C, Di Lorenzo F, Ponzo V, Pellicciari MC, et al
    Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2018;89:1237-1242.
    >> Share

    October 2018
  29. PAWLOWSKI M, Joksch V, Wiendl H, Meuth SG, et al
    Apraxia screening predicts Alzheimer pathology in frontotemporal dementia.
    J Neurol Neurosurg Psychiatry. 2018 Oct 10. pii: jnnp-2018-318470.
    >> Share

    August 2018
  30. SAWADA H, Oeda T, Kohsaka M, Umemura A, et al
    Early use of donepezil against psychosis and cognitive decline in Parkinson's disease: a randomised controlled trial for 2 years.
    J Neurol Neurosurg Psychiatry. 2018 Aug 3. pii: jnnp-2018-318107.
    >> Share

    July 2018
  31. VIK-MO AO, Bencze J, Ballard C, Hortobagyi T, et al
    Advanced cerebral amyloid angiopathy and small vessel disease are associated with psychosis in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2018 Jul 27. pii: jnnp-2018-318445.
    >> Share

  32. DI LAZZARO V
    Emergence of neurophysiological biomarkers of Alzheimer disease.
    J Neurol Neurosurg Psychiatry. 2018 Jul 21. pii: jnnp-2018-318867.
    >> Share

    June 2018
  33. KITAMURA S, Shimada H, Niwa F, Endo H, et al
    Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2018 Jun 8. pii: jnnp-2018-317970.
    >> Share

  34. AGARWAL S, Koch G, Hillis AE, Huynh W, et al
    Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke.
    J Neurol Neurosurg Psychiatry. 2018 Jun 4. pii: jnnp-2017-317371.
    >> Share

    January 2018
  35. BOUSIGES O, Bombois S, Schraen S, Wallon D, et al
    Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.
    J Neurol Neurosurg Psychiatry. 2018 Jan 10. pii: jnnp-2017-316385.
    >> Share

    December 2017
  36. SOUSA ALVES G
    CSF beta-amyloid and white matter damage: unravelling the neuropathology of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2017 Dec 16. pii: jnnp-2017-317053.
    >> Share

  37. KING E, O'Brien JT, Donaghy P, Morris C, et al
    Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias.
    J Neurol Neurosurg Psychiatry. 2017 Dec 16. pii: jnnp-2017-317134.
    >> Share

  38. CONNOR JR
    CSF ferritin predicts CSF Abeta decline in biomarker-determined Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2017 Dec 8. pii: jnnp-2017-317050.
    >> Share

  39. BROWN JM, Lansdall CJ, Wiggins J, Dawson KE, et al
    The Test Your Memory for Mild Cognitive Impairment (TYM-MCI).
    J Neurol Neurosurg Psychiatry. 2017;88:1045-1051.
    >> Share

    November 2017
  40. BANERJEE G, Carare R, Cordonnier C, Greenberg SM, et al
    The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.
    J Neurol Neurosurg Psychiatry. 2017;88:982-994.
    >> Share

  41. HARPER L, Bouwman F, Burton EJ, Barkhof F, et al
    Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis.
    J Neurol Neurosurg Psychiatry. 2017;88:908-916.
    >> Share

    October 2017
  42. PIETROBONI AM, Scarioni M, Carandini T, Basilico P, et al
    CSF beta-amyloid and white matter damage: a new perspective on Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2017 Oct 20. pii: jnnp-2017-316603.
    >> Share

  43. CARSWELL CJ, Win Z, Muckle K, Kennedy A, et al
    Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients.
    J Neurol Neurosurg Psychiatry. 2017 Oct 10. pii: jnnp-2017-316194.
    >> Share

    September 2017
  44. AYTON S, Diouf I, Bush AI
    Evidence that iron accelerates Alzheimer's pathology: a CSF biomarker study.
    J Neurol Neurosurg Psychiatry. 2017 Sep 22. pii: jnnp-2017-316551.
    >> Share

  45. DARBY RR, Brickhouse M, Wolk DA, Dickerson BC, et al
    Effects of cognitive reserve depend on executive and semantic demands of the task.
    J Neurol Neurosurg Psychiatry. 2017;88:794-802.
    >> Share

    August 2017
  46. LAI KSP, Liu CS, Rau A, Lanctot KL, et al
    Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies.
    J Neurol Neurosurg Psychiatry. 2017 Aug 9. pii: jnnp-2017-316201.
    >> Share

    July 2017
  47. MCKIERNAN EF, O'Brien JT
    7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature.
    J Neurol Neurosurg Psychiatry. 2017;88:564-574.
    >> Share

    March 2017
  48. WOODHEAD ZV, Crinion J, Teki S, Penny W, et al
    Auditory training changes temporal lobe connectivity in 'Wernicke's aphasia': a randomised trial.
    J Neurol Neurosurg Psychiatry. 2017 Mar 4. pii: jnnp-2016-314621.
    >> Share

    February 2017
  49. PRESSMAN PS, Simpson M, Gola K, Shdo SM, et al
    Observing conversational laughter in frontotemporal dementia.
    J Neurol Neurosurg Psychiatry. 2017 Feb 24. pii: jnnp-2016-314931.
    >> Share

  50. LEMSTRA AW, de Beer MH, Teunissen CE, Schreuder C, et al
    Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies.
    J Neurol Neurosurg Psychiatry. 2017;88:113-118.
    >> Share

    November 2016
  51. FERRARI R, Wang Y, Vandrovcova J, Guelfi S, et al
    Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
    J Neurol Neurosurg Psychiatry. 2016 Nov 29. pii: jnnp-2016-314411.
    >> Share

  52. AHMED S, Baker I, Thompson S, Husain M, et al
    Utility of testing for apraxia and associated features in dementia.
    J Neurol Neurosurg Psychiatry. 2016;87:1158-1162.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016